NO20005885D0 - Kombinasjonsterapi for behandling av refraktær depresjon - Google Patents

Kombinasjonsterapi for behandling av refraktær depresjon

Info

Publication number
NO20005885D0
NO20005885D0 NO20005885A NO20005885A NO20005885D0 NO 20005885 D0 NO20005885 D0 NO 20005885D0 NO 20005885 A NO20005885 A NO 20005885A NO 20005885 A NO20005885 A NO 20005885A NO 20005885 D0 NO20005885 D0 NO 20005885D0
Authority
NO
Norway
Prior art keywords
treatment
combination therapy
refractory depression
refractory
depression
Prior art date
Application number
NO20005885A
Other languages
English (en)
Other versions
NO20005885L (no
Inventor
Gary Dennis Tollefson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20005885D0 publication Critical patent/NO20005885D0/no
Publication of NO20005885L publication Critical patent/NO20005885L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Medicines Containing Plant Substances (AREA)
NO20005885A 1998-05-22 2000-11-21 Kombinasjonsterapi for behandling av refraktær depresjon NO20005885L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8644498P 1998-05-22 1998-05-22
PCT/US1999/011276 WO1999061027A1 (en) 1998-05-22 1999-05-21 Combination therapy for treatment of refractory depression

Publications (2)

Publication Number Publication Date
NO20005885D0 true NO20005885D0 (no) 2000-11-21
NO20005885L NO20005885L (no) 2001-01-17

Family

ID=22198612

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005885A NO20005885L (no) 1998-05-22 2000-11-21 Kombinasjonsterapi for behandling av refraktær depresjon

Country Status (24)

Country Link
EP (1) EP0958824A3 (no)
JP (1) JP2002516282A (no)
KR (1) KR20010043730A (no)
CN (1) CN1154496C (no)
AU (1) AU761510B2 (no)
BR (1) BR9911049A (no)
CA (1) CA2332814C (no)
CZ (1) CZ20004279A3 (no)
EA (1) EA004539B1 (no)
HK (1) HK1040055B (no)
HR (1) HRP20000797A2 (no)
HU (1) HUP0101901A3 (no)
ID (1) ID26861A (no)
IL (1) IL139592A (no)
MY (1) MY127938A (no)
NO (1) NO20005885L (no)
NZ (1) NZ507980A (no)
PL (1) PL344331A1 (no)
SK (1) SK17512000A3 (no)
TR (1) TR200003443T2 (no)
TW (1) TWI226829B (no)
UA (1) UA78181C2 (no)
WO (1) WO1999061027A1 (no)
ZA (1) ZA200006815B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000030648A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
SI1237553T1 (sl) * 1999-12-06 2006-06-30 Lundbeck & Co As H Kombinacija inhibitorja ponovnega navzema serotonina in antagonista 5-ht 2c?, inverznega agonista ali delnega agonista
AU2002232470B2 (en) * 2001-01-02 2005-11-03 Pharmacia & Upjohn Company Llc New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
US7973043B2 (en) 2002-07-30 2011-07-05 Peter Migaly Combination therapy for depression, prevention of suicide, and various medical and psychiatric conditions
BR0317771A (pt) 2002-12-27 2005-11-22 Otsuka Pharma Co Ltd Composição farmacêutica, uso da mesma, e, método de tratar distúrbios em um paciente
AR042806A1 (es) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
FR2851163B1 (fr) * 2003-02-14 2007-04-27 Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament
BRPI0413750A (pt) * 2003-09-04 2006-10-24 Lundbeck & Co As H uso de loxapina ou de um seu sal farmaceuticamente aceitável, composição farmacêutica, e, kit
CN103788089A (zh) 2003-09-17 2014-05-14 詹森药业有限公司 作为血清素受体调节剂的稠合杂环化合物
WO2005053703A1 (en) 2003-12-02 2005-06-16 Leslie James Sheldon Combination therapy for dementia, depression and apathy
JP2007513896A (ja) * 2003-12-15 2007-05-31 ハー・ルンドベック・アクチエゼルスカベット セロトニン再取り込み阻害剤およびヒスタミン３受容体アンタゴニスト、インバースアゴニストまたはパーシャルアゴニストの併用
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
JP2009506069A (ja) * 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
WO2007144005A1 (en) 2006-06-16 2007-12-21 H. Lundbeck A/S 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment
JP5467870B2 (ja) * 2007-02-09 2014-04-09 アルファファーム ピーティーワイ リミテッド 異なる物理的形態の２種以上の有効医薬成分を含有する投薬形態
TWI432194B (zh) * 2007-03-20 2014-04-01 Lundbeck & Co As H ４-〔２-（４-甲基苯硫基）苯基〕哌啶之新穎治療用途
JP6440625B2 (ja) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー 精神分裂病を処置するための方法および組成物
CN105769875A (zh) * 2014-12-22 2016-07-20 扬子江药业集团上海海尼药业有限公司 复方奥氮平盐酸氟西汀胶囊的制备方法
CN108938645A (zh) * 2018-08-24 2018-12-07 山西医科大学第医院 一种抗精神病药物组合物
CN111084778B (zh) * 2019-12-31 2022-06-24 北京鑫开元医药科技有限公司 一种奥氮平盐酸氟西汀胶囊及其制备方法
CN114569566A (zh) * 2020-12-02 2022-06-03 四川科瑞德制药股份有限公司 一种盐酸米那普仑制剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8072691A (en) * 1990-06-28 1992-01-23 Beecham Group Plc Pharmaceutical preparations
FR2716680B1 (fr) * 1994-02-25 1996-04-05 Adir Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
HUP9903679A3 (en) * 1996-03-11 2001-10-29 Lilly Co Eli Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
CN1146421C (zh) * 1996-03-25 2004-04-21 伊莱利利公司 治疗疼痛的组合物以及药物在制备所述组合物中的应用
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses

Also Published As

Publication number Publication date
JP2002516282A (ja) 2002-06-04
CN1154496C (zh) 2004-06-23
EP0958824A2 (en) 1999-11-24
CA2332814A1 (en) 1999-12-02
IL139592A (en) 2005-08-31
SK17512000A3 (sk) 2002-02-05
NO20005885L (no) 2001-01-17
EA004539B1 (ru) 2004-06-24
CA2332814C (en) 2008-11-04
EP0958824A3 (en) 1999-12-01
ID26861A (id) 2001-02-15
BR9911049A (pt) 2001-02-06
IL139592A0 (en) 2002-02-10
CN1311681A (zh) 2001-09-05
WO1999061027A1 (en) 1999-12-02
CZ20004279A3 (cs) 2001-09-12
UA78181C2 (en) 2007-03-15
NZ507980A (en) 2003-10-31
HK1040055B (zh) 2005-04-01
HRP20000797A2 (en) 2001-10-31
PL344331A1 (en) 2001-11-05
AU761510B2 (en) 2003-06-05
HK1040055A1 (en) 2002-05-24
EA200001218A1 (ru) 2001-06-25
KR20010043730A (ko) 2001-05-25
HUP0101901A3 (en) 2002-06-28
TR200003443T2 (tr) 2001-03-21
HUP0101901A2 (hu) 2001-11-28
ZA200006815B (en) 2002-01-14
AU4008699A (en) 1999-12-13
MY127938A (en) 2007-01-31
TWI226829B (en) 2005-01-21

Similar Documents

Publication Publication Date Title
NO20005885L (no) Kombinasjonsterapi for behandling av refraktær depresjon
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO991381L (no) Kombinasjonsterapi for behandling av psykoser
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
NO20010882D0 (no) Terapier for behandling av lungesykdommer
EP1077704A4 (en) COMBINATION THERAPY FOR TREATING DEPRESSION
NO20022087L (no) Fremgangsmåte for behandling av diabetes
IL136960A0 (en) Combination therapy for the treatment of migraine
NO20003229L (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske midler for behandling av proliferaktive sykdommer
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20020784L (no) Medikament for behandling av brudd
HUP0101947A3 (en) Combination for the treatment of tumors
NO994258L (no) Anvendelse av levobupivakain for behandling av ansiktsmigrene
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
IL136962A0 (en) Combination therapy for the treatment of migraine
IL136025A0 (en) Combination therapy for the treatment of migraine
IL136024A0 (en) Combination therapy for the treatment of migraine
NO20011268D0 (no) Forbindelse til behandling av depresjon
NO996166L (no) FremgangsmÕte for behandling av avluter
NO20042166L (no) Kombinasjonsterapi for behandling av sykdom
GB9926985D0 (en) Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia